Cargando…
Empowering rare disease patients through patient education: the new BehçeTalk programme
BACKGROUND: Educating patients and caregivers on their disease can improve their knowledge and promote the active involvement in the therapeutic decision-making process. Naturally, patient education programmes are critically important in rare systemic autoimmune diseases, where relevant knowledge an...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883708/ https://www.ncbi.nlm.nih.gov/pubmed/35220963 http://dx.doi.org/10.1186/s41927-022-00247-1 |
_version_ | 1784660004581670912 |
---|---|
author | Marinello, D. Del Bianco, A. Manzo, A. Mosca, M. Talarico, R. |
author_facet | Marinello, D. Del Bianco, A. Manzo, A. Mosca, M. Talarico, R. |
author_sort | Marinello, D. |
collection | PubMed |
description | BACKGROUND: Educating patients and caregivers on their disease can improve their knowledge and promote the active involvement in the therapeutic decision-making process. Naturally, patient education programmes are critically important in rare systemic autoimmune diseases, where relevant knowledge and expertise still remain scattered. Behçet’s disease (BD) represents a challenging rare condition, characterized by a variable spectrum of disease profile and a relapsing course. RESULTS: Recently, BehçeTalk, an educational programme tailored for BD patients, families and caregivers with, was launched. BehçeTalk, entirely co-designed with BD patients, is offering educational on-line webinars on different aspects of the disease, as well support groups for patients and caregivers coordinated by a psychologist with specific expertise in BD. CONCLUSIONS: The therapeutical management of BD is often challenging and frequently includes off-label treatments. Considering the specificities of BD, providing a specific education on the disease to patients will lead to empower them in being part of the decision-making processes, in the self-management and in improving their quality of life. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41927-022-00247-1. |
format | Online Article Text |
id | pubmed-8883708 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88837082022-03-07 Empowering rare disease patients through patient education: the new BehçeTalk programme Marinello, D. Del Bianco, A. Manzo, A. Mosca, M. Talarico, R. BMC Rheumatol Commentary BACKGROUND: Educating patients and caregivers on their disease can improve their knowledge and promote the active involvement in the therapeutic decision-making process. Naturally, patient education programmes are critically important in rare systemic autoimmune diseases, where relevant knowledge and expertise still remain scattered. Behçet’s disease (BD) represents a challenging rare condition, characterized by a variable spectrum of disease profile and a relapsing course. RESULTS: Recently, BehçeTalk, an educational programme tailored for BD patients, families and caregivers with, was launched. BehçeTalk, entirely co-designed with BD patients, is offering educational on-line webinars on different aspects of the disease, as well support groups for patients and caregivers coordinated by a psychologist with specific expertise in BD. CONCLUSIONS: The therapeutical management of BD is often challenging and frequently includes off-label treatments. Considering the specificities of BD, providing a specific education on the disease to patients will lead to empower them in being part of the decision-making processes, in the self-management and in improving their quality of life. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41927-022-00247-1. BioMed Central 2022-02-28 /pmc/articles/PMC8883708/ /pubmed/35220963 http://dx.doi.org/10.1186/s41927-022-00247-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Commentary Marinello, D. Del Bianco, A. Manzo, A. Mosca, M. Talarico, R. Empowering rare disease patients through patient education: the new BehçeTalk programme |
title | Empowering rare disease patients through patient education: the new BehçeTalk programme |
title_full | Empowering rare disease patients through patient education: the new BehçeTalk programme |
title_fullStr | Empowering rare disease patients through patient education: the new BehçeTalk programme |
title_full_unstemmed | Empowering rare disease patients through patient education: the new BehçeTalk programme |
title_short | Empowering rare disease patients through patient education: the new BehçeTalk programme |
title_sort | empowering rare disease patients through patient education: the new behçetalk programme |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883708/ https://www.ncbi.nlm.nih.gov/pubmed/35220963 http://dx.doi.org/10.1186/s41927-022-00247-1 |
work_keys_str_mv | AT marinellod empoweringrarediseasepatientsthroughpatienteducationthenewbehcetalkprogramme AT delbiancoa empoweringrarediseasepatientsthroughpatienteducationthenewbehcetalkprogramme AT manzoa empoweringrarediseasepatientsthroughpatienteducationthenewbehcetalkprogramme AT moscam empoweringrarediseasepatientsthroughpatienteducationthenewbehcetalkprogramme AT talaricor empoweringrarediseasepatientsthroughpatienteducationthenewbehcetalkprogramme |